LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 68.37 | 27.76 | 182 | 6879 | 0.0265 | 0.2667 | MN20160318_Q01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 68.37 | 27.76 | 2368 | 6879 | 0.3442 | 0.7490 | MN20160318_Q01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 68.37 | 27.76 | 406 | 6879 | 0.0590 | 0.4012 | MN20160318_Q01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 68.37 | 27.76 | 2788 | 6879 | 0.4053 | 0.7853 | MN20160318_Q01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 70.08 | 27.76 | 163 | 6849 | 0.0238 | 0.2495 | MN20160318_Q01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 70.08 | 27.76 | 2464 | 6849 | 0.3597 | 0.7586 | MN20160318_Q01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 70.08 | 27.76 | 438 | 6849 | 0.0639 | 0.4150 | MN20160318_Q01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 70.08 | 27.76 | 2867 | 6849 | 0.4186 | 0.7924 | MN20160318_Q01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 71.78 | 27.76 | 175 | 6893 | 0.0254 | 0.2604 | MN20160318_Q01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 71.78 | 27.76 | 2560 | 6893 | 0.3714 | 0.7659 | MN20160318_Q01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 71.78 | 27.76 | 430 | 6893 | 0.0624 | 0.4112 | MN20160318_Q01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 71.78 | 27.76 | 2966 | 6893 | 0.4303 | 0.7989 | MN20160318_Q01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 73.48 | 27.76 | 178 | 6957 | 0.0256 | 0.2626 | MN20160318_Q01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 73.48 | 27.76 | 2628 | 6957 | 0.3777 | 0.7700 | MN20160318_Q01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 73.48 | 27.76 | 418 | 6957 | 0.0601 | 0.4054 | MN20160318_Q01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 73.48 | 27.76 | 3045 | 6957 | 0.4376 | 0.8030 | MN20160318_Q01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 75.19 | 27.76 | 183 | 7015 | 0.0261 | 0.2665 | MN20160318_Q01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 75.19 | 27.76 | 2754 | 7015 | 0.3926 | 0.7789 | MN20160318_Q01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 75.19 | 27.76 | 471 | 7015 | 0.0671 | 0.4258 | MN20160318_Q01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 75.19 | 27.76 | 3150 | 7015 | 0.4490 | 0.8091 | MN20160318_Q01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 76.89 | 27.76 | 219 | 7025 | 0.0312 | 0.2953 | MN20160318_Q01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 76.89 | 27.76 | 2884 | 7025 | 0.4105 | 0.7889 | MN20160318_Q01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 76.89 | 27.76 | 446 | 7025 | 0.0635 | 0.4160 | MN20160318_Q01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 76.89 | 27.76 | 3253 | 7025 | 0.4631 | 0.8161 | MN20160318_Q01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 78.60 | 27.76 | 245 | 7045 | 0.0348 | 0.3134 | MN20160318_Q01 | H17 |